Avidity Biosciences, Inc. — Form D

Avidity Biosciences, Inc. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-11-13. The offering totals $103.8M, of which $100.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Todd BradyDirectorAtlanta, GA
NOREEN HENIGDirectorLA JOLLA, CA
EDWARD KAYEDirectorLA JOLLA, CA
MICHAEL MARTINDirectorMinneapolis, MN
Troy WilsonDirectorSan Francisco, CA
Roderick WongDirectorNew York, NY
Troy WilsonExecutive OfficerSan Francisco, CA
Noreen Michael HenigDirectorSan Diego, CA
Carsten Michael BoessDirectorSan Diego, CA
Troy Michael WilsonDirectorSan Diego, CA
Tamar Michael ThompsonDirectorSan Diego, CA
Sarah BoyceDirectorSan Diego, CA
Sarah BoyceExecutive OfficerSan Diego, CA
Teresa Michael McCarthyExecutive OfficerSan Diego, CA
Edward Michael KayeDirectorSan Diego, CA
Jean Michael KimDirectorSan Diego, CA
W. Michael FlanaganExecutive OfficerSan Diego, CA
Arthur LevinExecutive OfficerSan Diego, CA
Michael Michael MacLeanExecutive OfficerSan Diego, CA
P. Kent HawrylukExecutive OfficerCarmel, IN
Troy Wilson PhD., JDDirectorLa Jolla, CA
Troy Wilson PhD., JDExecutive OfficerLa Jolla, CA
Michael Martin PhD.DirectorLa Jolla, CA
Mark E DavisDirectorLa Jolla, CA
Frank E McCormickDirectorLa Jolla, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2024-03-19D$400.2M$400.2M
2017-01-06D$23.3M$18.0M
2014-02-18D$9.1M$9.1M
2014-02-18D/A$9.1M$9.1M

More